Opinion: How should we deal with COVID now?
LA TimesThe government made funding available for people infected with COVID to afford the drug Paxlovid for treatment, but not many people know how to access it. Another payment problem arises around antiviral medications such as Paxlovid — imperfect but useful tools to reduce death among those infected with the SARS-CoV-2 virus. After the COVID-19 public health emergency ended, the Department of Health and Human Services reached an agreement with Pfizer to increase access through the Paxcess program, which ensures that the drug is free for those on Medicaid and Medicare and the underinsured. The Department of Health and Human Services should embark on an expanded pharmacist and healthcare provider information initiative, working with all major pharmacy chains, to add electronic prompts for Paxcess to prescription fulfillment systems.